COMMUNIQUÉS West-GlobeNewswire

Arrayit Corporation Announces Allergy Testing Partnerships with Major Allergy Therapeutics Providers
27/08/2018
Sunnyvale, Aug. 27, 2018 (GLOBE NEWSWIRE) -- August 27, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces allergy testing partnerships with multiple [...]
Loxo Oncology Announces Submission of European Marketing Authorization Application for Larotrectinib
27/08/2018
STAMFORD, Conn., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company developing highly selective medicines for patients with genomically defined cancers, today announced that [...]
Photocure ASA: Exclusive Nordic distribution agreement for innovative drug delivery system for bladder cancer patients
27/08/2018
Oslo, Norway, August 27, 2018 : Photocure ASA, The Bladder Cancer Company, announces today that an exclusive distribution agreement for the Nordic area for an innovative and patented medical device has been signed with [...]
FIT Biotech Oy: FIT Biotech has delivered the first batch of FIT-06 vaccine to EHVA clinical trials
27/08/2018
FIT Biotech Oy Press release 27.8.2018 at 08.30 AM EET FIT Biotech has delivered the first batch of FIT-06 vaccine to EHVA clinical trials FIT Biotech Ltd ("FIT Biotech", FITBIO: FN Finland) has delivered the first [...]
Novartis receives European Commission approval of its CAR-T cell therapy, Kymriah® (tisagenlecleucel)
27/08/2018
The EC approval is based on the first global CAR-T registration trials, which included patients from eight European countries and demonstrated durable responses and a consistent safety profile in r/r pediatric B-cell [...]
BeiGene Announces Acceptance of its First New Drug Application for Zanubrutinib in Relapsed/Refractory Mantle Cell Lymphoma by China Drug Administration
27/08/2018
BEIJING, China and CAMBRIDGE, Mass., Aug. 26, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Amarin’s REDUCE-IT™ Clinical Study Now Positioned to be Next Large Cardiovascular Outcomes Study to Report Results
26/08/2018
REDUCE-IT is the First Study of Any Therapy to Prospectively Enroll and Evaluate Risk Reduction for Cardiovascular Events in Statin-Treated Patients with Elevated Triglyceride Levels and Other Cardiovascular Risk [...]
Ozempic® consistently reduced the risk of major cardiovascular events across type 2 diabetes populations at high CV risk regardless of prior CV events at baseline
26/08/2018
Munich, Germany, 26 August 2018 - Ozempic ® (semaglutide) consistently reduced the risk of the composite outcome of time to first occurrence of non-fatal heart attack, non-fatal stroke or cardiovascular death ( [...]
Downtown Bethesda Welcomes its First Medical Cannabis Dispensary
25/08/2018
MPX Opens Health for Life Dispensary in Bethesda, Maryland Expanding its National Footprint BETHESDA, Md., Aug. 25, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE: MPX; OTC: MPXEF [...]
Novartis announces new data that show Entresto® (sacubitril/valsartan) can be initiated early & safely in hospitalized patients after an acute heart failure episode
25/08/2018
TRANSITION shows that Entresto can be safely initiated shortly after an acute heart failure episode, both in the hospital and in an out-patient setting and in a wide range of stabilized patients[1] 83% of chronic heart [...]
Real-World Data Supports Association Between Elevated Triglyceride Levels and Increased Peripheral Arterial Revascularization in High Risk Statin-Treated Patients
25/08/2018
Management to Host Conference Call at 8:00 a.m. ET August 27, 2018 to Discuss Data Presented at European Society of Cardiology Congress BEDMINSTER, N.J. and DUBLIN, Ireland, Aug. 25, 2018 (GLOBE NEWSWIRE) -- Amarin [...]
Biotricity Issues Statement Regarding Recent Promotional Activity
24/08/2018
REDWOOD CITY, Calif., Aug. 24, 2018 (GLOBE NEWSWIRE) -- Biotricity, Inc. (OTCQB:BTCY) (the “Company”) announced today that it has been made aware of and requested by the OTC Markets Group, Inc. to comment on recent [...]
MPX to Report Fiscal First Quarter 2019 Earnings on Wednesday, August 29, 2018
24/08/2018
TORONTO, Aug. 24, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE: MPX; OTC: MPXEF), today announced the Company will issue its fiscal first quarter 2019 results release on August [...]
American ‘Healthcare Voters’ Are Deceived about the Real Problems, States the Association of American Physicians and Surgeons (AAPS)
24/08/2018
TUCSON, Ariz., Aug. 24, 2018 (GLOBE NEWSWIRE) -- Recent polls show that “healthcare is the No. 1 issue for voters,” writes Robert Pearl in Forbes . Their concerns are quite valid, states the Association of American [...]
Oasmia Pharmaceutical publishes the Annual Report for 2017/2018
24/08/2018
Oasmia Pharmaceutical’s Annual Report for the fiscal year 2017/2018 is now available at the company’s website, www.oasmia.com . For further information, please contact: Anders Blom, CFO Tel : +46 (0)18 – 50 54 40 E-mail [...]
BioSyent to Present at Upcoming Investor Conference
24/08/2018
TORONTO, Aug. 24, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”) (TSX Venture: RX) is pleased to announce that it will be presenting at the Midwest IDEAS Investor Conference at The Gwen in Chicago, [...]
Latvijas Juras medicinas centrs JSC: interim report for the 6 months of 2018.
24/08/2018
Latvia, 2018-08-24 15:06 CEST (GLOBE NEWSWIRE) -- Latvijas Juras medicinas centrs JSC: interim report for the 6 months of 2018, approved by the Board at 22.08.2018. Member of the Board: Juris Imaks, phone: 29512492
Clinical Genomics is proud to support Strides for Life and Super Bowel I
24/08/2018
Overcoming the stigma associated with colorectal cancer screening; former NFL players lead the way by undertaking colonoscopy and InSure ONE FIT testing in Super Bowel I BRIDGEWATER, N.J., Aug. 24, 2018 (GLOBE NEWSWIRE [...]
Solon Eiendom ASA – Major shareholding and primary insider notification
24/08/2018
(Oslo, Norway, August 24, 2018) Alden AS has today sold 6.044.556 shares in Solon Eiendom ASA at a price of NOK 30.00 per share. Owner of Alden AS, Edvin Austbø, is married to Solon Eiendom ASA Board Member Heidi [...]

Pages